Drug Master Files for: cevimeline hydrochloride
✉ Email this page to a colleague
cevimeline hydrochloride Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
13074 | A | II | 7/17/1998 | ISHIHARA SANGYO KAISHA LTD | CEVIMELINE HYDROCHLORIDE |
22200 | A | II | 11/17/2008 | EXCELLA GMBH AND CO KG | CEVIMELINE HYDROCHLORIDE |
22509 | A | II | 2/6/2009 | APOTEX PHARMACHEM INC | CEVIMELINE HYDROCHLORIDE HEMIHYDRATE |
24949 | A | II | 10/31/2011 | APICORE US LLC | CEVIMELINE HYDROCHLORIDE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information